Skip to main content
SpringerLink
Log in

Methods of detecting prostatic tumors

  • Chapter
Genitourinary Cancer

Part of the book series: Cancer Treatment and Research ((CTAR,volume 34))

Abstract

It has been estimated that in 1985, 25,500 patients will die of carcinoma of the prostate and 86,000 new cases will be diagnosed [1]. Currently, prostate cancer is the third most common cause of cancer death in American males and accounts for 10% of such deaths [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Silverberg E: Cancer Statistics-1985. CA35: 19–35, 1985

    Google Scholar 

  2. Walsh PC, Jewett HJ: Radical surgery for prostatic cancer. Cancer 45: 1906–1911, 1980

    PubMed  CAS  Google Scholar 

  3. Hodges CV, Pearse HD, Stille L: Radical prostatectomy fot carcinoma: 30-year experience and 15-year survivals. J Urol 122: 180–182, 1979

    PubMed  CAS  Google Scholar 

  4. Catalona WJ, Scott WW: Carcinoma of the prostate. In: Campbell’s Urology, Walsh PC, Gittes RF, Perlmutter AD, Stamey (eds). 5th Edition. WB Saunders Company, Philadelphia, 1463–1534, 1986

    Google Scholar 

  5. Sheldon CA, Williams RD, Fraley EE: Incidental carcinoma of the prostate: A review of the literature and critical reappraisal of classification. J Urol 124: 626–630, 1980

    PubMed  CAS  Google Scholar 

  6. Murphy GP, Natarajan N, Pontes RL et al.: The national survey of prostate cancer in the United States by the American College of Surgeons, J Urol 127: 928–934, 1982

    PubMed  CAS  Google Scholar 

  7. Gutman AB, Gutman EB: ‘Acid’ phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostate gland. J Clin Invest 17: 473, 1938

    Article  PubMed  CAS  Google Scholar 

  8. Roy AV, Brower ME, Hayden JE: Sodium thymolphthalein monophosphate: A new acid phosphatase substrate with greater specificity for the prostatic enzyme in serum. Clin Chem 17: 1093–1102, 1971

    PubMed  CAS  Google Scholar 

  9. Nesbit RM, Baum WB: Serum phosphatase determination in diagnosis of prostatic cancer; a review of 1,150 cases. JAMA 145: 1321–1324, 1951

    CAS  Google Scholar 

  10. Murphy GP, Reynoso G, Kenny GM et al.: Comparison of total and prostatic fraction serum acid phosphatase levels in patients with differentiated and undifferentiated prostatic carcinoma. Cancer 23: 1309–1314, 1969

    Article  PubMed  CAS  Google Scholar 

  11. Ganem EJ: The prognostic significance of an elevated serum acid phosphatase level in advanced prostatic carcinoma. J Urol 76: 179–181, 1956

    PubMed  CAS  Google Scholar 

  12. Byar DP, Corle DK, VACURG: VACURG randomized trial of radical prostatectomy for stages I and II prostate cancer. Urology 17(4) suppl.: 7–11, 1981

    PubMed  CAS  Google Scholar 

  13. Whitesel JA, Donohue RE, Mani JH et al.: Acid phosphatase: Its influence on the management of carcinoma of the prostate. J Urol 131: 70–72, 1984

    PubMed  CAS  Google Scholar 

  14. Foti AG, Cooper JF, Herschman H et al.: Detection of prostate cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase. N Engl J Med 297: 1357–1361, 1977

    Article  PubMed  CAS  Google Scholar 

  15. Chu TM, Wang MC, Scott WW, et al.: Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation. Invest Urol 15: 319–323, 1978

    PubMed  CAS  Google Scholar 

  16. Vihko P, Sajatni E, Janne O, et al.: Serum prostate-specific acid phosphatase: development and validation of a specific radioimmunoassay. Clin Chem 24: 1915–1919, 1978

    PubMed  CAS  Google Scholar 

  17. Gittes RF: Acid phosphatase reappraised. N Engl J Med 297: 1398–1399, 1977

    Article  PubMed  CAS  Google Scholar 

  18. Bruce AW, Mahan DE, Sullivan LD, et al.: The significance of prostatic acid phosphatase in adenocarcinoma of the prostate. J Urol 125: 357–360, 1981

    PubMed  CAS  Google Scholar 

  19. Griffiths JD: Prostate-specific acid phosphatase: re-evaluation of radioimmunoassay in diagnosing prostatic disease. Clin Chem 26: 433–436, 1980

    PubMed  CAS  Google Scholar 

  20. Fair WR, Heston WDW, Kadmon D, et al.: Prostatic cancer, acid phosphatase, creatine kinase-BB and race: a prospective study. J Urol 128: 735–738, 1982

    PubMed  CAS  Google Scholar 

  21. Fleischmann J, Catalona WJ, Fair WR, et al.: Lack of value of radioimmunoassay for prostatic acid phosphatase as a screening test for prostatic cancer in patients with obstructive prostatic hyperplasia. J Urol 129: 312–314, 1983

    PubMed  CAS  Google Scholar 

  22. Vihko P, Kontturi M, Lukkarinen O, et al. Immunoreactive prostatic acid phosphatase in prostatic cancer: diagnosis and follow-up of patients. J Urol 133: 979–982, 1985

    PubMed  CAS  Google Scholar 

  23. Lindholm GR, Stirton MS, Liedtke RJ, et al.: Prostatic acid phosphatase bu radioimmunoassay JAMA 244: 2071–2073, 1980

    CAS  Google Scholar 

  24. Carson JL, Eisenberg JM, Shaw LM. et al.: Diagnostic accuracy of four assays of prostatic acid phosphatase. JAMA 253: 665–669, 1985

    Article  PubMed  CAS  Google Scholar 

  25. Pontes EJ: Biological markers in prostate cancer. K Urol 130: 1037–1047, 1983

    CAS  Google Scholar 

  26. Quinones GR, Rohner Jr TJ, Drago et al.: Will prostatic acid phosphatase of early prostatic cancer? J Urol 125: 361–364, 1981

    PubMed  CAS  Google Scholar 

  27. Watson RA, Tang DB: The predictive value of prostatic acid phosphatase as a screening test for prostatic cancer. N Engl J Med 303: 497–499, 1980

    Article  PubMed  CAS  Google Scholar 

  28. Kiesling VJJr, Watson RA: A closer look at serum prostatic acid phosphatase as a screening test. Urology 16: 242–244, 1980

    Article  PubMed  Google Scholar 

  29. Feld R, Witte D: Presence of creatine kinase BB isoenzyme in some patients with prostatic cancer. Clin Chem 23: 1930–1932, 1977

    PubMed  CAS  Google Scholar 

  30. Silverman L, Chapman J, Jones M, et al.: Creatine kinase BB and other markers of prostatic carcinoma. Prostate 2: 109–119, 1981

    Article  PubMed  CAS  Google Scholar 

  31. Forman DT: The significance of creatine kinase (CKBB) in metastatic cancer of the prostate. Ann Clin Lab Sci 9: 333–337, 1979

    PubMed  CAS  Google Scholar 

  32. Wang NC, Valenzuela LA, Murphy GP, et al.: Purification of a human prostate specific antigen. Invest Urol 17: 159–163, 1979

    PubMed  CAS  Google Scholar 

  33. Wang MC, Papsidero LD, Kuriyama M, et al.: Prostate antigen: a new potential marker ofr prostatic cancer. Prostate 2: 89–96, 1981

    Article  PubMed  CAS  Google Scholar 

  34. Kuriyama M, Wang MC, Lee CI, et al.: Use of human prostate-specific antigen in monitoring prostate cancer. Cancer Res 41: 3874–3876, 1981

    PubMed  CAS  Google Scholar 

  35. Pontes JE, Chu TM, Slack N, et al.: Serum prostatic antigen measurement in localized prostatic cancer: correlation with clinical course. J Urol 128: 1216–1218, 1982

    PubMed  CAS  Google Scholar 

  36. Wajsman Z, Chu JM, Bross D, et al.: Clinical significance of serum alkaline phosphatase isoenzymes in advanced prostate carcinoma. J Urol 119: 244–246, 1978

    PubMed  CAS  Google Scholar 

  37. Denis LJ, Prout Jr GR: Lactic dehydrogenase in prostatic cancer. Incest Urol 1: 101–111, 1963

    CAS  Google Scholar 

  38. Prout GR Jr, Macalalaf Jr EV, Fenis LJ, et al.: Alterations in serum lactate dehydrogenase and its fourth and fifth isozymes in patients with prostatic cancer. J Urol 94: 451–461, 1965

    PubMed  CAS  Google Scholar 

  39. Killian CS, Vargas FP, Beckley, et al.: Analysis of serial erthrocyte polyamines by automated reverse-phase liquid chromatography (HPLC). Clin Chem abstract 122, 26: 983, 1980

    Google Scholar 

  40. Chiasiri P, Harper M, Blarney R, et al.: Plasma spermidine concentrations in patients with tumors of the breast or prostate or testis. Clin Chem Acta 104: 367–375, 1980

    Article  Google Scholar 

  41. Durie BOM, Salmon SE, Russell DH: Polyamines as markers of response and disease activity in cancer chemotherapy. Cancer Res 37: 214–221, 1977

    PubMed  CAS  Google Scholar 

  42. Fair WR, Wehner N, Bronsson U: Urinary polyamine levels in the diagnosis of carcinoma of the prostate. J Urol 114: 88–92, 1975

    PubMed  CAS  Google Scholar 

  43. Belitsky P, Elhilali MM, Oliver JA, et al.: Serum lactate dehydrogenase isoenzyme changes in carcinoma of the prostate. J Urol 103: 770–773, 1970

    PubMed  CAS  Google Scholar 

  44. Grayhack JT, Lee C: Evaluation of prostatic fluid in prostatic pathology. In: The prostatic cell structure and function, Murphy GP, Sandberg AA, Karr JP (eds). Liss New York, 231, 1981

    Google Scholar 

  45. Catalona WJ, Menon M: New screening and diagnostic tests for prostate cancer and immunologic assessment. Urology 17(3) suppl. 61–65, 1981

    PubMed  CAS  Google Scholar 

  46. Levitt RG, Sagel SS, Stanley RJ, et al.: Computed tomography of the pelvis. Semin Roentgenol 13: 192–200, 1978

    Article  Google Scholar 

  47. Rifkin MD: The prostate and seminal vesicles, in Rifkin MD (ed): Diagnostic imaging of the lower genitourinary tract. Raven Press, New York, 122–208, 1985

    Google Scholar 

  48. Rickards D, Gowland M, Brooman P, et al.: computed tomography and transrectal ultrasound in the diagnosis of prostatic disease - a comparative study. Br J Urol 55: 726–732, 1983

    Article  PubMed  CAS  Google Scholar 

  49. Hricak H, Williams RD, Spring DB et al.: Anatomy and pathology of the male pelvis by magnetic resonance imaging. AJR 141: 1101–1110, 1983

    PubMed  CAS  Google Scholar 

  50. Bryan PJ, Butler HE, Luma Jp: Magnetic resonance imaging of the pelvis. Radiol Clin of North Am 22: 897–915, 1984

    CAS  Google Scholar 

  51. Dooms GC, Hricak H, Crooks Higgins CB: Magnetic resonance imaging of the lymph nodes: comparison with CT. Radiology 153: 719–728, 1984

    PubMed  CAS  Google Scholar 

  52. Lee JKT, Heiken JP, Ling D, et al.: Magnetic resonance imaging of abdominal and pelvis lymphadenopathy. Radiolgy 153: 181–188, 1984

    CAS  Google Scholar 

  53. Watanabe H, Kaiho H, Tonaka M, et al.: Diagnostic application of ultrasonotomography to the prostate. Invest Urol 8: 548–559, 1971

    PubMed  CAS  Google Scholar 

  54. Watanabe H, Saitoh M, Mishina T, et al.: Mass screening program for prostatic diseases with transrectal ultrasonotomography. J Urol 117: 746–748, 1977

    PubMed  CAS  Google Scholar 

  55. Harada K, Tanashashi Y, Igari D, et al.: Clinical evaluation of inside echo patterns in gray scale prostatic echography. J Urol 124: 216–220, 1980

    PubMed  CAS  Google Scholar 

  56. Gammelgaard J, Holm HH: Transurethral and transrectal ultrasonic scanning in urology. J Urol 124: 863–868, 1980

    PubMed  CAS  Google Scholar 

  57. Watanabe H, Date S, Ohe H, et al.: A survey of 3,000 examinations by transrectal ultrasonotomography. Prostate 1: 271–278, 1980

    Article  PubMed  CAS  Google Scholar 

  58. Resnick MI: Evaluation of prostatic carcinoma: noninvasive and preoperative techniques. Prostate 1:311–320, 1980

    Article  PubMed  CAS  Google Scholar 

  59. Brooman PJC, Griffiths GJ, Roberts E, et al.: Per rectal ultrasound in the investigation of prostatic disease. Clin Radiol 32: 669–676, 1981

    Article  PubMed  CAS  Google Scholar 

  60. Brooman PJC, Peeling WB, Griffiths GJ, et al.: A comparison between digital examination and per-rectal ultrasound in the evaluation of the prostate. Br J Urol 53: 617–620, 1981

    Article  PubMed  CAS  Google Scholar 

  61. Hastak SM, Gammelgaard J, holm HH: Transrectal ultrasonic volume determination of the prostate - a preoperative and postoperative study. J Urol 127: 1115–1118, 1982

    PubMed  CAS  Google Scholar 

  62. Hastak SM, Gammelgaard J, Holm HH: Ultrasonically guided transperineal biopsy in the diagnosis of prostatic carcinoma. J Urol 128: 69–71, 1982

    PubMed  CAS  Google Scholar 

  63. Peeling WB, Griffiths GJ: Imaging of the prostate by ultrasound. J Urol 132: 217–224, 1984

    PubMed  CAS  Google Scholar 

  64. Fritzsche PJ, Axford PD, Ching VJ, et al.: Correlation of transrectal sonographic findings in patients with suspected and unsuspected prostatic disease. J Urol 130: 272–273, 1983

    PubMed  CAS  Google Scholar 

  65. Rifkin MD, Kurtz AB, Choi HY, et al.: Endoscopic ultrasonic evaluation of the prostate using a transrectal probe: prospective evaluation and acoustic charactirization. Radiology 149: 264–271, 1983

    Google Scholar 

  66. Pontes EJ, Ohe H, Watanabe H, et al.: Transrectal ultrasonography of the prostate. Cancer 53: 1369–1372, 1984

    Article  PubMed  CAS  Google Scholar 

  67. Pontes EJ, Eisenkraft S, Watanabe H, et al.: Preoperative evaluation of localized prostatic carcinoma by transrectal ultrasonography. J Urol 134: 289–291, 1985

    PubMed  CAS  Google Scholar 

  68. Fujina A, Scardino PT: Transrectal ultrasonography for prostatic cancer: its value in staging and monitoring the response to radiotherapy and chemotherapy. J Urol 133: 806–810, 1985

    Google Scholar 

  69. Lee F, Gray JM, McLeary RD, et al.: Transrectal ultrasound in the diagnosis of prostate cancer: location echogenicity, histopathology and staging. Prostate 7: 117–129, 1985

    Article  PubMed  CAS  Google Scholar 

  70. Catalona WJ: Yield from routine prostatic needle biopsy in patients more than 50 years old referred for urologic evaluation: A preliminary report. J Urol 124: 844–846, 1980

    PubMed  CAS  Google Scholar 

  71. Grayhack JT, Bockrath JM: Diagnosis of carcinoma of the prostate. Urology 17(3) Suppl: 54–60, 1981

    PubMed  CAS  Google Scholar 

  72. Silverberg E, Lubera JA: A review of American Cancer society estimates of cancer cases and deaths. CA 33: 2–25, 1983

    PubMed  CAS  Google Scholar 

  73. Hutchison GB: Incidence and etiology of prostate cancer. Urology 17(3) Suppl: 4–10, 1981

    PubMed  CAS  Google Scholar 

  74. Pressman D, Korngold L: The in vivo localization of anti-Wagner osteogenic sarcoma antibodies. Cancer 6: 7619–7623, 1953

    Article  Google Scholar 

  75. Goldenberg DM, DeLand FH, Kim EE, et al.: Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med 298: 1384–1386, 1978

    Article  PubMed  CAS  Google Scholar 

  76. Larson SM, Carrasquillo JA, Krohn KA, Muffin RW, Hellstrom I, Hellstrom KE, Lyster D: Diagnostic imaging of malignant melanoma with radiolabeled anti-tumor antiboedies. JAMA 249: 811–812, 1983

    Article  PubMed  CAS  Google Scholar 

  77. Goldenberg DM, DeLand FH, Bennett SJ, et al.: Radioimmunodetection of prostatic cancer: In vivo use of radioactive antibodies against prostatic acid phosphatase for diagnosis and detection of prostatic cancer by nuclear imaging. JAMA 250: 630–635, 1983

    Article  PubMed  CAS  Google Scholar 

  78. Ter-Pogossian M, Phelps ME, Hoffman EJ, et al.: A positron emission transaxial tomography for nuclear imaging (PETT). Radiology 114: 89–98, 1975

    PubMed  CAS  Google Scholar 

  79. Phelps ME, Kühl DE, Mazziotta JC: Metabolic mapping of the brain’s response to visual stimulation: studies in humans. Science 211: 1445–1448, 1981

    Article  PubMed  CAS  Google Scholar 

  80. Phelps ME, Mazziotta JC: Positron emission tomography: Human brain function and biochemistry. Science 228: 799–809, 1985

    Article  PubMed  CAS  Google Scholar 

  81. Schelbert HR: Blood flow and substrate use in normal and diseased myocardium pp. 342–348: In Phelps Me, Moderator. Positron computed tomography for studies of myocardial and cerebral function. Ann Intern Med 98: 339–359, 1983

    PubMed  Google Scholar 

  82. Fair WR, Miller TR, Siegel BA et al.: Radionuclide imaging of dog prostate. Urology 12: 575–578, 1978

    Article  PubMed  CAS  Google Scholar 

  83. Beaney RP: Position emission tomography in the study of human tumors. Semin Nucl Med 14: 324–341, 1984

    Article  PubMed  CAS  Google Scholar 

  84. Guinan P, Bush I, Ray V, et al.: The accuracy of the rectal examination in the diagnosis of prostate carcinoma. N Engl J Med 303: 499–503, 1980

    Article  PubMed  CAS  Google Scholar 

  85. Gilbertson VA: Cancer of the prostate gland: results of early diagnosis and therapy undertaken for cure of the disease. JAMA 215: 81–84, 1971

    Article  Google Scholar 

  86. Donohue RE, Fauver HE, Whitesel JA et al.: Staging prostatic cancer: a different distribution. J Urol 122: 327–329, 1979

    PubMed  CAS  Google Scholar 

  87. Thompson IA, Ernst JJ, Gangai MP, et al.: Adenocarcinoma of the prostate: results of routine urological screening. J Urol 132: 690–692, 1984

    PubMed  CAS  Google Scholar 

  88. Chodak GW, Schoenberg HW: Early detection of prostate cancer by routine screening. JAMA 252: 3261–3264, 1984

    Article  PubMed  CAS  Google Scholar 

  89. Vihko P, Kontturi M, Lukkarinen O, et al.: Screening for carcinoma of the prostate. Cancer 56: 173–177, 1985

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Dov Kadmon
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Jewish Hospital of St. Louis, Washington University School of Medicine, 216 South Kingshighway Boulevard, P.O. Box 14109, 63178, St. Louis, MO, USA

    Timothy L. Ratliff Ph.D.

  2. The Jewish Hospital of St. Louis, Washington University School of Medicine, 63178, St. Louis, MO, USA

    William J. Catalona M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Martinus Nijhoff Publishers, Boston

About this chapter

Cite this chapter

Kadmon, D. (1987). Methods of detecting prostatic tumors. In: Ratliff, T.L., Catalona, W.J. (eds) Genitourinary Cancer. Cancer Treatment and Research, vol 34. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2033-3_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2033-3_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9210-4

  • Online ISBN: 978-1-4613-2033-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation